300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Sweden
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Albania
Angola
Europe
Dominican Republic
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Investinor, VC Fund

Investinor

VC Fund

Trondheim, Norway

Investinor is a VC fund in Trondheim focused on Software and Biotechnology. Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.

Total investments:
133
Last investment:
Lead investor:
51%
Fund size:
$274M
Last fund:

Last updated:

Industries Investinor invests in

SoftwareBiotechnologyManufacturingInformation TechnologyHealth Care

Stages Investinor invests in

Venture - Series UnknownFunding RoundSeries ASeedSeries B

Countries Investinor invests in

NorwayUnited StatesSwedenSwitzerlandUnited Kingdom

Round sizes

Series A $2.3M–$25MVenture - Series Unknown $2M–$19M

Contacts

NameEmailPhoneSocials
See all 13 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2.3M–$25M
Venture - Series Unknown
$2M–$19M

Investment Focus

Industry

  • Software 23 (17%)
  • Biotechnology 16 (12%)
  • Manufacturing 13 (10%)
  • Information Technology 13 (10%)
  • Health Care 11 (8%)
See all 136 industries →

Stage

  • Venture - Series Unknown 32 (24%)
  • Funding Round 26 (20%)
  • Series A 22 (17%)
  • Seed 20 (15%)
  • Series B 9 (7%)
See all 8 stages →

Country

  • Norway 82 (62%)
  • United States 4 (3%)
  • Sweden 1 (1%)
  • Switzerland 1 (1%)
  • United Kingdom 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Bent Grøver
Bent Grøver Principal
Principal Total investments: 1
Find email
Otto Frøseth
Otto Frøseth Investment Director
Investment Director Total investments: 3
Find email
Ann-Tove Kongsnes
Ann-Tove Kongsnes Investment Director
Investment Director Total investments: 9
Find email
Birgitte Gangmark Villmo
Birgitte Gangmark Villmo Investment Manager
Investment Manager Total investments: 1
Find email
Egil Garberg
Egil Garberg Investment Associate
Investment Associate Total investments: 5
Find email
See all 13 team members →

Investments

CompanyDescriptionRoundLinks
Muybridge is a imaging platform that develops software and sensors for cameras. $16M / Series A / May 21, 2026
Two Two
Two is a B2B payments and financial technology company that provides buy now, pay later, and net-term payment solutions for businesses. Its platform enables merchants to offer flexible payment terms across online, direct, and in-store sales while automating credit checks, fraud assessment, invoicing, payment collection, and receivables management.Two also provides APIs and tools for integrating B2B payment and credit services into commerce systems. $15.2M / Series A / Jul 11, 2025
Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows. $75.5M / Series A / Jul 09, 2025
Kongsberg Ferrotech provides robotic services underwater with integrated inspection, repair, and maintenance solutions. Kongsberg Ferrotech enhances offshore renewables by addressing intricate degradation issues and introducing cutting-edge robotic solutions for the inspection and repair of underwater assets. $14.1M / Seed / Jul 09, 2025
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. $24.7M / Series A / Mar 26, 2025
EXACT Therapeutics is a clinical-stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range oftherapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. $13.1M / Post-IPO Equity / Dec 03, 2024
Heimdall Power is a technology company specializing in smart grid solutions for the energy sector. They focus on optimizing and digitizing power grid infrastructure to enhance efficiency, reliability, and sustainability. These sensors are installed on power lines to provide real-time data on various parameters, including temperature, load, and linesag. They help in monitoring and managing the grid more effectively. Heimdall Power's mission is to revolutionize the way power grids are managed by providing real-time data and advanced analytics to improve grid performance and facilitate the transition to renewable energy sources. $25M / Series B / Jul 16, 2024
Keenious uses an AI recommendation engine to analyze documents, understand their content, and compare them to millions of scientific publications. This tool helps users discover relevant research by identifying shared rare terms between the text and articles' titles and abstracts. Keenious integrates with platforms like Microsoft Word andGoogle, providing summaries and relevant articles to enhance research and knowledge discovery. $1.4M / Venture - Series Unknown / Jun 04, 2024
Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology. $7.6M / Venture - Series Unknown / Feb 21, 2024
Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases. $81.4M / Series A / Jan 23, 2024
See all 133 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Sweden
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Albania
Angola
Europe
Dominican Republic
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Investinor invest in?

Investinor invests primarily in Software, Biotechnology and Manufacturing startups, most often at Venture - Series Unknown and Funding Round stage. Most of the 133 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Investinor invest in?

Investinor typically joins rounds of $2.3M–$25M at Series A and $2M–$19M at Venture - Series Unknown. These are whole funding-round sizes, not Investinor's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Investinor took part in.

How do I contact Investinor?

Public channels for Investinor include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Investinor?

The team at Investinor includes Bent Grøver (Principal), Otto Frøseth (Investment Director) and Ann-Tove Kongsnes (Investment Director), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Investinor Investinor Find emails